Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Intangibles (2018 - 2025)

Silence Therapeutics' Intangibles history spans 8 years, with the latest figure at $288000.0 for Q4 2025.

  • On a quarterly basis, Intangibles fell 7.69% to $288000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $288000.0, a 7.69% decrease, with the full-year FY2025 number at $288000.0, down 7.69% from a year prior.
  • Intangibles hit $288000.0 in Q4 2025 for Silence Therapeutics, down from $300000.0 in the prior quarter.
  • Over the last five years, Intangibles for SLN hit a ceiling of $377911.7 in Q2 2023 and a floor of $4135.8 in Q3 2021.
  • Historically, Intangibles has averaged $245884.1 across 5 years, with a median of $312000.0 in 2024.
  • Biggest five-year swings in Intangibles: plummeted 71.86% in 2021 and later soared 1474.56% in 2023.
  • Tracing SLN's Intangibles over 5 years: stood at $175241.4 in 2021, then soared by 114.18% to $375337.1 in 2022, then dropped by 6.09% to $352487.1 in 2023, then decreased by 11.49% to $312000.0 in 2024, then decreased by 7.69% to $288000.0 in 2025.
  • Business Quant data shows Intangibles for SLN at $288000.0 in Q4 2025, $300000.0 in Q3 2025, and $317000.0 in Q2 2025.